Earnings

Coloplast Q3 Adj. EPS $0.10, Inline, Sales $1.144B Beat $1.120B Estimate

Aug 18, 2026 · 05:04 AM ET· updated 1h ago

Coloplast (OTC:CLPBY) reported quarterly earnings of $0.10 per share which met the analyst consensus estimate. This is a 66.67 percent increase over earnings of $0.06 per share from the same period last year. The

Why It Matters

Coloplast made more money than expected this quarter, and earned way more per share than last year. When a company beats sales targets and grows earnings fast, it shows the business is doing well and people trust it.

This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.

Tickers in Play

CLPBY6.58

-0.10 (-1.50%)

Last session drawn · prints held ~15 minutes · licensed exchange data

Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.

Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.